APA (7th ed.) Citation

S, H., F, K., S, M., D, B., M, S., & W, S. Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients. Dove Medical Press.

Chicago Style (17th ed.) Citation

S, Hölsken, Krefting F, Mühlhaus S, Bese D, Schedlowski M, and Sondermann W. Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients. Dove Medical Press.

MLA (9th ed.) Citation

S, Hölsken, et al. Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients. Dove Medical Press.